Serum Exo-EphA2 as a Potential Diagnostic Biomarker for Pancreatic Cancer
Conclusions
Novel findings suggest that serum Exo-EphA2 is a potential early diagnostic biomarker complementing CA 19-9 and CA 242 in PC.
Source: Pancreas - Category: Gastroenterology Tags: Original Articles Source Type: research
More News: Cancer | Cancer & Oncology | Carbohydrates | Gastroenterology | Pancreas | Pancreatic Cancer | Study